Dissemination of Findings Fast Using Online-videos Trial (DIFFUSION)

A Randomize Controlled Trial of the Effect of Emotional Content on the Extent to Which an On-line Medical Educational Video is Forwarded.

The investigators will conduct a two-arm, randomized controlled trial of the effect of emotional content in online videos on the extent to which the video is disseminated (forwarded). Dissemination can be assessed in terms of the number of views which can increase as a result from sharing and forwarding of the video.

In this study, an experiment video and a control video, both of which are approximately 2.5 minutes long, will be uploaded on YouTube, the most visited video sharing website. The videos concern the WOMAN trial, a large RCT of tranexamic acid in postpartum hemorrhage. The experimental group will receive a video with strongly emotional content (an interview with a postpartum hemorrhage survivor and her husband). The control group will receive a short video in which a researcher conveys the same information (but without the first hand experience of the survivor and her husband). Otherwise, the two videos are identical.

Participants, selected from clinicians and researchers in obstetrics and gynecology, will be randomly allocated to two groups. An e-mail with a link to either of the videos will be sent to the participants. In the e-mail, they will be asked to watch the video and forward the link to their colleagues if they find it helpful.

The primary outcome is video forwarding. The secondary outcome is the number of access to the video that each participant generated.

Data will be collected for 14 days after the e-mails are sent to the participants. The relative risk (RR) of forwarding the videos will be calculated as effect measure and compared using chi-square test. The distribution of the numbers of access to the video that each participant generated will be compared using Wilcoxon signed-rank test.

The hypothesis is that an online video with emotional content has higher chance of being forwarded to other people and therefore, gets higher number of views than an less emotional online video.

Study Overview

Detailed Description

[Statistical analysis plan for the DIFFUSION trial]

SETTING

Two videos will be uploaded on YouTube through a new account created for this study. The uploaded videos will be embedded in two independent websites with white background. A computer programme has been created to collect the data of access to the videos.

International journals in obstetrics and gynaecology published in 2013 and 2014 will be sought for participant recruitment. The authors of the articles published in the journals who met the inclusion criteria will be assigned ID numbers and randomised to receive either the intervention or control video. Randomised participants will be sent a unique web address (URL) of the video that they are allocated to by e-mail via a mass e-mailing service, Campaign Monitor. Each URL will be linked to the participant's ID number in the database. They will be asked to watch the video and forward it to their colleagues if they find it helpful. If a randomised participant forwards their URL to another person, and that person clicks on it, the click will be recorded against the participant's ID number in the computer programme. Therefore, if there are multiple accesses from the same ID number, it is either because the participant watched the video more than once or because the participant forwarded the URL and other people watched the video.

This trial will be coordinated from the London School of Hygiene & Tropical Medicine (University of London) and conducted worldwide online.

SAMPLE SIZE AND STATISTICAL POWER

Two main factors determine the number of patients needed in a trial. These are the estimated event rate and size of the treatment effect. The investigators will power the trial for our main outcome: percentage of participants that forwarded the video at least once in each arm.

ESTIMATED EVENT RATE: Based on other studies, baseline e-mail forward rate was assumed to be 10%.

SAMPLE SIZE AND SIZE OF INTERVENTION EFFECT THAT SHOULD BE DETECTABLE: Assuming the change from baseline is 7.5% (75% increase from 10% to 17.5%), the sample size required for this study was calculated. The calculation suggested 1000 participants, 500 per group, are required to test the null hypothesis at the 5% significance level with 90% power. We learnt from the pilot trial that around 14% of e-mail recipients click on the link and watch the video. In order to get 1000 participants to watch the videos, 7000 participants will be required given the video viewing rate of 14%.

CRITERIA FOR EVALUATION

All participants randomly assigned to one of the videos will be analysed together, regardless of whether or not they watched the video, on an intention to treat basis. This analysis is to examine the effect of the intervention in a practical scenario. In addition, only those who watched the videos will be analysed on a per-protocol basis to estimate the efficacy of the intervention.

RANDOMISATION

An independent statistician will randomly allocate the ID numbers of the participants to either the intervention or the control groups using a computer programme. Allocation will be concealed to a person who will recruit participants. Randomisations were balanced 1:1.

BLINDING AND UNBLINDING

As two videos are apparently different, participants cannot be blinded in this trial. However, each participant is not sent the other video so in principle they cannot tell if they received a video with more or less emotional content. The study coordinator who will conduct data analyses is masked to the allocation. The data will be unblinded after this SAP is submitted to the ClinicalTrial.gov and all data analyses have been completed. The data are kept in a password-secured online archive (Google drive). Access to the data is limited to the trial coordinator and technical assistant who developed the computer programme for data collection.

ANALYSIS PRINCIPLES FOR FINAL ANALYSIS

  • Two different analyses will be conducted for the primary outcome on an intention-to-treat basis and a per-protocol basis.
  • All tests will be two-sided, and the nominal level of α will be 5% for the main analysis.
  • All statistical analyses will be unadjusted except where indicated.
  • Missing values will not be imputed unless specified otherwise. Where the number of missing observations is substantial, the number of observations used in the analysis will be reported.
  • P values will not be adjusted for multiplicity. However, the outcomes are clearly categorised by degree of importance (primary and secondary).

DATA COLLECTION AND OUTCOME ASSESSMENT

Every time someone clicks on a URL to access a video our computer program collects four variables: (a) ID number (b) IP address from which the URL is clicked, (c) date and time of access (recorded in Great British Time regardless of the country of the IP address) and (d) type of device (web browser, phone or computer device)

Definition of access by the same person to a video:

As there is no way to detect forwarding, accesses to the video by unique individuals will be counted as the closest indicator of forwarding. It is also impossible to precisely distinguish an access by a unique individual, in other words, to tell if the video was accessed more than once by the same person or by different people. Therefore, the investigators need to make assumptions based on the data collected by our programme. In the main analysis, the investigators will consider that accesses with the same ID number from the same IP address mean that a person watched the video more than once. Accesses with the same ID number from different IP addresses will be considered as accesses by unique individuals. The data of the other variables (time and type of device) will be considered in the sensitivity analysis. Multiple accesses with the same ID from the same IP address within five minutes will be counted as one access, allowing for the possibility that a person watched the video more than once because the video did not play the first time or the parson wanted to confirm the information in the video.

CHARACTERISTICS OF PARTICIPANTS AND BASELINE COMPARISONS

Description of the baseline characteristics listed below will be presented by intervention group. The countries which the participants are based in were categorised into low, middle and high income countries based on the classification by the World Bank. Discrete variables will be summarised by frequencies and percentages. Percentages will be calculated according to the number of participants for whom data are available. Where values are missing, the denominator (which is less than the number of patients assigned to the treatment group) will be stated in either the body or footnote of the corresponding summary table.

Continuous variables will be summarised using standard measures of central tendency and dispersion, i.e. either a mean or a median with SD.

DESCRIPTION OF ANALYSES

The outcome assessor will be masked to the identity of each participant by using ID numbers instead of individual names or e-mail addresses.

Accesses to the videos will be counted as a substitute for the measure of forwarding. Therefore, even if a participant forwarded the URL to another person, if the person does not click on the link, that forwarding will not be counted. This leads to the underestimate of the effect of the intervention.

PRIMARY OUTCOME: A standard chi-square test will be used as the primary test of statistical significance of the effect of intervention allocation on the proportion of video forwarding. Frequencies and percentages per arm, and a risk ratio measuring the intervention effect and its 95% confidence interval (CI) will also be reported.

SECONDARY OUTCOMES: Distribution of number of accesses generated by each participant will be compared. The difference in the means (SD) in each arm will be estimated in order to assess the effect of the intervention along with the P value. To test the statistical difference in distribution, Wilcoxon signed-rank test will be conducted. In case the distributions are complex, the data will be stratified into a few groups and chi-square test will be conducted to test the statistical difference in distribution.

After assessing the distributions, a t-test and Mood's median test will be conducted to test the statistical difference in the mean and median of the number of access to the videos that each participant generated respectively.

SENSITIVITY ANALYSES: The effect of the intervention may vary according to the definition of an access by a unique person. Therefore, the investigators will conduct sensitivity analyses for all outcomes using two different definitions of an access by a unique person: most conservative definition and most liberal definition.

The possible largest effect of the intervention and the difference in all the outcomes between the two groups will be estimated using the most liberal definition of forwarding. Likewise, the possible smallest effect of the intervention and the difference in all the outcomes between the two groups will be estimated using the most conservative definition. With the most liberal definition, the investigators will count all accesses as those by different persons. With the most conservative definition, the investigators will count accesses as those by different persons only if the data from all the categories are different.

Study Type

Interventional

Enrollment (Actual)

8353

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • London, United Kingdom, WC1E 7HT
        • London School of Hygiene and Tropical Medicine

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Clinicians and researchers in obstetrics and gynaecology who have an e-mail address.

Exclusion Criteria:

  • Clinicians and researchers who are in the countries where YouTube cannot be accessed (China, Iran, Pakistan and Turkmenistan).

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: emotional content
A short online video with emotional content, an interview with a postpartum hemorrhage survivor and her husband talking about their experience.
Active Comparator: less emotional content
A short online video with less emotional content, the WOMAN trial coordinator talks about the experience of a postpartum hemorrhage survivor and her husband.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of Participants Who Forwarded the Video
Time Frame: After 14 days of sending the online videos
A computer programme to track the access to the videos has been made. The number of people who forwarded the video will be analysed based on the data collected with this programme.
After 14 days of sending the online videos

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of Access to the Video Generated as a Result of Video Sharing by Each Participant
Time Frame: After 14 days of sending the online videos
The distribution of the numbers of access to the video that each participant generated will be compared using the data collected with the computer programme to track access to the videos.
After 14 days of sending the online videos

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

December 1, 2014

Primary Completion (Actual)

March 1, 2015

Study Completion (Actual)

March 1, 2015

Study Registration Dates

First Submitted

April 7, 2014

First Submitted That Met QC Criteria

April 8, 2014

First Posted (Estimate)

April 9, 2014

Study Record Updates

Last Update Posted (Estimate)

December 28, 2016

Last Update Submitted That Met QC Criteria

October 27, 2016

Last Verified

June 1, 2016

More Information

Terms related to this study

Other Study ID Numbers

  • QA534

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Information Seeking Behavior

Clinical Trials on A short online video with emotional content

3
Subscribe